Levitz Michael L bought ANIK
March 15, 2024 · Form 4 insider transaction
Levitz Michael L bought 51,682 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
51,682
Price
$0.00
Total value
N/A
InsiderLevitz Michael L
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 15, 2024
Filing dateMarch 19, 2024
Shares owned after51,682
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a 10% premium above the closing price of Anika's common stock on the date of grant.; The premium priced stock options vest in three equal annual installments beginning on March 15, 2025.